Skip to content

Electroencephalographic responsiveness to ultrasound stimulation of the vagus nerve predicts the efficacy of VNS in the treatment of medically refractory epilepsy

Electroencephalographic responsiveness to ultrasound stimulation of the vagus nerve predicts the efficacy of VNS in the treatment of medically refractory epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092906
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug-refractory epilepsy

Interventions

Modeling group:none
Validation group:none

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Males or females aged >= 1 year and <= 60 years old; 2.Diagnosis of medically refractory epilepsy; 3.Patient proposed for vagus nerve stimulator placement; 4.Subjects or their guardians are able to understand the purpose of the trial, have good adherence to the trial protocol, participate voluntarily and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Suffering from mental illness and unable to cooperate with treatment; 2.Accompanied by intrauterine distress, obstructed labor, cerebral hemorrhage, and other conditions that may lead to secondary epilepsy; 3.Severe cardiovascular and cerebrovascular diseases, severe liver and renal function abnormalities, and other systemic illnesses that have serious impacts on health; 4.Pregnant or intending to be pregnant women, and breastfeeding women; 5.Neck trauma, skin ulcers, and structural abnormalities of the blood vessels in the neck; 6.Those who, in the opinion of the investigator, should not participate in the clinical trial;

Design outcomes

Primary

MeasureTime frame
McHugh grading;modified Engel grading;

Secondary

MeasureTime frame
Quality of Life in Eye Diseases-31;Latent Severity Score Scale;

Countries

China

Contacts

Public ContactGuo Yanwu

Zhujiang Hospital of Southern Medical University

dguoyanwu@163.com+86 13711432687

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026